Literature DB >> 9836491

Serum levels of pro- and anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion.

S Vassiliadis1, A Ranella, L Papadimitriou, A Makrygiannakis, I Athanassakis.   

Abstract

Disturbance of the cytokine equilibrium has been accused for many pathological disorders. Microbial infections, autoimmune diseases, graft rejection have been correlated to over- or under-production of specific cytokines which are produced as responder molecules to the various immune stimuli. The sole naturally occurring immune reaction in the organism is developed during the gestational period where, despite the presence of a semi-allogeneic graft, maternal immunoreactivity is driven to support fetal growth. The successful embryo development has been attributed to the important intervention of cytokines where some have been characterized as indispensable and others deleterious to fetal growth. However, the physiological levels of many factors during the gestational process have not been determined. Thus, in the present study we have measured and established the values of IL-1alpha, IL-2, IL-3, IL-4, IL-6, IL-10, IL-12, GM-CSF, TNF-alpha and IFN-gamma during all phases of human pregnancy (first, second and third trimester of pregnancy, labour, abortions of the first trimester) as well as in the non-pregnant control state. This is an attempt to assess serum protein concentrations and present the physiological levels of these cytokines at certain time intervals providing thus a diagnostic advantage in pregnancy cases where the mother cannot immunologically support the fetus. Exploitation of this knowledge and further research may be useful for therapeutic interventions in the future.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9836491      PMCID: PMC1781827          DOI: 10.1080/09629359891199

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  13 in total

1.  Paternal leukocytes selectively increase secretion of IL-4 in peripheral blood during normal pregnancies: demonstrated by a novel one-way MLC measuring cytokine secretion.

Authors:  C Ekerfelt; L Matthiesen; G Berg; J Ernerudh
Journal:  Am J Reprod Immunol       Date:  1997-11       Impact factor: 3.886

Review 2.  [Role of the placenta in maintaining the fetal allograft].

Authors:  G Chaouat; E Menu; P Bustany; C Rebut-Bonneton; J Szekeres-Bartho; T G Wegmann
Journal:  Reprod Nutr Dev       Date:  1988

3.  Inhibition of pregnancy viability in mice following IL-2 administration.

Authors:  B U Tezabwala; P M Johnson; R C Rees
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

4.  Elevations of serum interleukin-12 concentrations in women with severe pre-eclampsia and HELLP syndrome.

Authors:  D J Dudley; C Hunter; M D Mitchell; M W Varner; M Gately
Journal:  J Reprod Immunol       Date:  1996-08       Impact factor: 4.054

Review 5.  Acting on the cytokine balance to control auto-immunity and chronic inflammation.

Authors:  P Miossec
Journal:  Eur Cytokine Netw       Date:  1993 Jul-Aug       Impact factor: 2.737

Review 6.  The Th1/Th2 balance in autoimmunity.

Authors:  B Charlton; K J Lafferty
Journal:  Curr Opin Immunol       Date:  1995-12       Impact factor: 7.486

7.  Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.

Authors:  C S Tripp; S F Wolf; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Expression of tumor necrosis factor-alpha and -beta transcripts in embryonal carcinoma and trophoblast cell lines: inflammation-like state as possible regulatory mechanism for ontogenesis.

Authors:  C Kohchi; D Mizuno; G Soma
Journal:  Eur Cytokine Netw       Date:  1991 Aug-Sep       Impact factor: 2.737

9.  Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming.

Authors:  R A Seder; R Gazzinelli; A Sher; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

10.  Cytokine production in the serum and spleen of mice from day 6 to 14 of gestation: cytokines/placenta/spleen/serum.

Authors:  I Athanassakis; B Iconomidou
Journal:  Dev Immunol       Date:  1996
View more
  32 in total

Review 1.  Interplay between T helper type 1 and type 2 cytokines and soluble major histocompatibility complex molecules: a paradigm in pregnancy.

Authors:  Irene Athanassakis; S Vassiliadis
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

Review 2.  Immunology of pregnancy. Implications for the mother.

Authors:  Jill A Poole; Henry N Claman
Journal:  Clin Rev Allergy Immunol       Date:  2004-06       Impact factor: 8.667

3.  Variations in cytokine mRNA expression during normal human pregnancy.

Authors:  N Kruse; M Greif; N F Moriabadi; L Marx; K V Toyka; P Rieckmann
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

4.  Human labour is associated with altered regulatory T cell function and maternal immune activation.

Authors:  N M Shah; L F Edey; N Imami; M R Johnson
Journal:  Clin Exp Immunol       Date:  2019-11-03       Impact factor: 4.330

Review 5.  Pregnancy as a cardiac stress model.

Authors:  Eunhee Chung; Leslie A Leinwand
Journal:  Cardiovasc Res       Date:  2014-01-20       Impact factor: 10.787

6.  Positive association of Apolipoprotein E4 polymorphism with recurrent pregnancy loss in Iranian patients.

Authors:  Nooshin Asgari; Mohammad Taghi Akbari; Shohre Zare; Gholamreza Babamohammadi
Journal:  J Assist Reprod Genet       Date:  2013-01-08       Impact factor: 3.412

7.  Maternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection?

Authors:  Roberto Romero; Nicholas Kadar; Edi Vaisbuch; Sonia S Hassan
Journal:  Am J Reprod Immunol       Date:  2010-03-15       Impact factor: 3.886

Review 8.  Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.

Authors:  Shernan G Holtan; Douglas J Creedon; Paul Haluska; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

9.  Longitudinal changes in serum proinflammatory markers across pregnancy and postpartum: effects of maternal body mass index.

Authors:  Lisa M Christian; Kyle Porter
Journal:  Cytokine       Date:  2014-07-28       Impact factor: 3.861

10.  Stress-induced inflammatory responses in women: effects of race and pregnancy.

Authors:  Lisa M Christian; Ronald Glaser; Kyle Porter; Jay D Iams
Journal:  Psychosom Med       Date:  2013-07-19       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.